402
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Positive Predictive Value of ICD-10-CM Codes for Myocarditis in Claims Data: A Multi-Institutional Study in Taiwan

, & ORCID Icon
Pages 459-468 | Received 21 Jan 2023, Accepted 01 Apr 2023, Published online: 06 Apr 2023

References

  • Ali-Ahmed F, Dalgaard F, Al-Khatib SM. Sudden cardiac death in patients with myocarditis: evaluation, risk stratification, and management. Am Heart J. 2020;220:29–40. doi:10.1016/j.ahj.2019.08.007
  • Dasgupta S, Iannucci G, Mao C, Clabby M, Oster ME. Myocarditis in the pediatric population: a review. Congenit Heart Dis. 2019;14(5):868–877.
  • Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med. 2021;21(5):e505–e510.
  • Hang W, Chen C, Seubert JM, Wang DW. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes. Signal Transduct Target Ther. 2020;5(1):287.
  • Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604–1615.
  • Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Lane DA, Lip GYH. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021;51(11):e13679.
  • Singh B, Kaur P, Cedeno L, et al. COVID-19 mRNA Vaccine and Myocarditis. Eur J Case Rep Intern Med. 2021;8(7):002681.
  • Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27):977–982.
  • Naveed Z, Li J, Spencer M, et al. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. 2022;194(45):E1529–e1536.
  • Pillay J, Gaudet L, Wingert A, et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. BMJ. 2022;378:e069445.
  • Voleti N, Reddy SP, Ssentongo P. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:951314.
  • Wang W, Wang CY, Wang SI, Wei JC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619.
  • Esposito S, Caminiti C, Giordano R, Argentiero A, Ramundo G, Principi N. Myocarditis Following COVID-19 Vaccine Use: can It Play a Role for Conditioning Immunization Schedules? Front Immunol. 2022;13:915580.
  • Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ. 2021;375:e068665.
  • Kildegaard H, Lund LC, Højlund M, Stensballe LG, Pottegård A. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study. BMJ. 2022;377:e068898.
  • Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med. 2021;385(23):2132–2139.
  • Wong H-L, Hu M, Zhou CK, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022;399(10342):2191–2199.
  • Lai FTT, Chan EWW, Huang L, et al. Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis. J Am Coll Cardiol. 2022;80(24):2255–2265.
  • Idowu RT, Carnahan R, Sathe NA, McPheeters ML. A systematic review of validated methods to capture myopericarditis using administrative or claims data. Vaccine. 2013;31:K34–K40.
  • Howard A, Hasan A, Brownlee J, et al. Pediatric Myocarditis Protocol: an Algorithm for Early Identification and Management with Retrospective Analysis for Validation. Pediatr Cardiol. 2020;41(2):316–326.
  • Shao SC, Chan YY, Kao Yang YH, et al. The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593–600.
  • Su YC, Hung JH, Chang KC, et al. Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan. JAMA Netw Open. 2022;5(9):e2232584.
  • Shao SC, Chang KC, Lin SJ, et al. Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2021;20(1):213.
  • Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerg Infect Dis. 2021;27(12):3175–3178.
  • Chen HK, Shao SC, Weng MY, et al. Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor-α Inhibitors. Clin Pharmacol Ther. 2021;110(6):1595–1603.
  • Shao SC, Lin YH, Chang KC, et al. Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients? BMJ Open Diabetes Res Care. 2019;7(1):e000742.
  • Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–2648.
  • Grigoratos C, Di Bella G, Aquaro GD. Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis. Heart Fail Rev. 2019;24(1):81–90.
  • Blissett S, Chocron Y, Kovacina B, Afilalo J. Diagnostic and prognostic value of cardiac magnetic resonance in acute myocarditis: a systematic review and meta-analysis. Int J Cardiovasc Imaging. 2019;35(12):2221–2229.
  • Howard A, Hasan A, Brownlee J, et al. Pediatric myocarditis protocol: an algorithm for early identification and management with retrospective analysis for validation. Pediatr Cardiol. 2020;41(2):316–326.
  • Law YM, Lal AK, Chen S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation. 2021;144(6):e123–e135.
  • Chiang MY, Shao SC, Liao SC. Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan’s Claims Data. Front Pharmacol. 2022;13:882632.
  • Liao SC, Shao SC, Lai EC, Lin SJ, Huang WI, Hsieh CY. Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database. Clin Epidemiol. 2022;14:1–7.
  • Fayol A, Livrozet M, Boutouyrie P, et al. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021;8(3):2232–2239.
  • Sagar S, Liu PP, Cooper LT. Myocarditis. Lancet. 2012;379(9817):738–747.
  • Tsai MJ, Tsai CH, Pan RC, Hsu CF, Sung SF. Validation of ICD-9-CM and ICD-10-CM Diagnostic Codes for Identifying Patients with Out-of-Hospital Cardiac Arrest in a National Health Insurance Claims Database. Clin Epidemiol. 2022;14:721–730.
  • Tsai MJ, Tsai CH, Pan RC, Hsu CF, Sung SF. Validation of ICD-9-CM and ICD-10-CM Diagnostic Codes for Identifying Patients with Out-of-Hospital Cardiac Arrest in a National Health Insurance Claims Database. Clin Epidemiol. 2022;14:721.
  • Gray K, Cameron S, McKenzie K, Miller M, Odoardi N, Tijssen JA. Validation of ICD-10 codes for the identification of paediatric out-of-hospital cardiac arrest patients. Resuscitation. 2022;171:73–79.
  • Saunders-Hastings P, Heong SW, Srichaikul J, et al. Acute myocardial infarction: development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database. PLoS One. 2021;16(7):e0253580.
  • Bezin J, Girodet PO, Rambelomanana S, et al. Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database. Fundam Clin Pharmacol. 2015;29(6):586–591.
  • Sundbøll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6(11):e012832.
  • Younis A, Matetzky S, Mulla W, et al. Epidemiology Characteristics and Outcome of Patients With Clinically Diagnosed Acute Myocarditis. Am J Med. 2020;133(4):492–499.
  • Lota AS, Hazebroek MR, Theotokis P, et al. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. Circulation. 2022;146(15):1123–1134.
  • Sharma AN, Stultz JR, Bellamkonda N, Amsterdam EA. Fulminant Myocarditis: epidemiology, Pathogenesis, Diagnosis, and Management. Am J Cardiol. 2019;124(12):1954–1960.
  • Kragholm KH, Lindgren FL, Zaremba T, et al. Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study. Open Heart. 2021;8(2):e001806.